drugset / Trial / NCT00625833

A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.

NCT00625833 ↗

Phase 2 Terminated 330 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a trial to investigate the effectiveness and safety of \[S,S\]-Reboxetine in relieving chronic peripheral pain suffered by patients with diabetes. Some evidence for the effectiveness of \[S,S\]- Reboxetine in relieving chronic pain has been seen in 3 completed trials.

Timeline

Start
2007-12
Primary completion
2008-11
Completion
2008-11

Outcome

Outcome not reported

Stopped: “Study was terminated for futility following the planned interim analysis.”

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown — Oral

Indications